Fisher Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2B | Buy |
|
|||||
|
2025
Q1 | $1.16B | Buy |
|
|||||
|
2024
Q4 | $637M | Buy |
|
|||||
|
2024
Q3 | $759M | Buy |
|
|||||
|
2024
Q2 | $682M | Buy |
|
|||||
|
2024
Q1 | $672M | Buy |
|
|||||
|
2023
Q4 | $557M | Buy |
|
|||||
|
2023
Q3 | $493M | Sell |
|
|||||
|
2023
Q2 | $493M | Buy |
|
|||||
|
2023
Q1 | $473M | Buy |
|
|||||
|
2022
Q4 | $447M | Buy |
|
|||||
|
2022
Q3 | $358M | Sell |
|
|||||
|
2022
Q2 | $852M | Buy |
|
|||||
|
2022
Q1 | $826M | Buy |
|
|||||
|
2021
Q4 | $803M | Buy |
|
|||||
|
2021
Q3 | $681M | Buy |
|
|||||
|
2021
Q2 | $699M | Buy |
|
|||||
|
2021
Q1 | $608M | Buy |
|
|||||
|
2020
Q4 | $608M | Buy |
|
|||||
|
2020
Q3 | $611M | Buy |
|
|||||
|
2020
Q2 | $648M | Buy |
|
|||||
|
2020
Q1 | $589M | Buy |
|
|||||
|
2019
Q4 | $724M | Buy |
|
|||||
|
2019
Q3 | $652M | Buy |
|
|||||
|
2019
Q2 | $554M | Sell |
|
|||||
|
2019
Q1 | $609M | Buy |
|
|||||
|
2018
Q4 | $539M | Buy |
|
|||||
|
2018
Q3 | $563M | Buy |
|
|||||
|
2018
Q2 | $557M | Buy |
|
|||||
|
2018
Q1 | $525M | Buy |
|
|||||
|
2017
Q4 | $453M | Sell |
|
|||||
|
2017
Q3 | $521M | Buy |
|
|||||
|
2017
Q2 | $540M | Buy |
|
|||||
|
2017
Q1 | $505M | Buy |
|
|||||
|
2016
Q4 | $455M | Sell |
|
|||||
|
2016
Q3 | $512M | Buy |
|
|||||
|
2016
Q2 | $511M | Buy |
|
|||||
|
2016
Q1 | $500M | Buy |
|
|||||
|
2015
Q4 | $465M | Buy |
|
|||||
|
2015
Q3 | $443M | Sell |
|
|||||
|
2015
Q2 | $480M | Buy |
|
|||||
|
2015
Q1 | $496M | Sell |
|
|||||
|
2014
Q4 | $460M | Sell |
|
|||||
|
2014
Q3 | $528M | Buy |
|
|||||
|
2014
Q2 | $608M | Buy |
|
|||||
|
2014
Q1 | $599M | Buy |
|
|||||
|
2013
Q4 | $593M | Sell |
|
|||||
|
2013
Q3 | $558M | Sell |
|
|||||
|
2013
Q2 | $557M | Buy |
|